A recent assessment of drug use in Suva has unveiled troubling trends in methamphetamine injection practices that pose significant public health risks, particularly regarding the transmission of HIV and viral hepatitis among drug users. The study, conducted by researchers from the Kirby Institute in Australia, involved interviews with 56 individuals engaged in drug use or injection.
The findings highlighted dangerous practices, including needle sharing and risky methods of drug preparation. Virginia McDonald from the Kirby Institute pointed out a concerning technique referred to as “Koda,” where methamphetamine is mixed with the user’s blood in the syringe instead of water—a practice that escalates the risk of these infections.
McDonald emphasized that it is not the act of drug use itself that increases the risk of HIV or hepatitis, but rather the sharing of needles and syringes. During the interviews, the research revealed little evidence of the widely reported practice known as “Bluetoothing,” but confirmed that individuals were reusing syringes, which remains a serious concern.
Dr. Dashika Balak, the Acting Head of the National HIV Outbreak and Cluster Response, underscored the need for effective harm reduction strategies in Fiji, especially given the alarming increase of nearly 3000 percent in HIV infections since 2010. Fiji, once ranked second in new infections, now leads the Pacific region in HIV cases, highlighting the urgent demand for interventions.
Health officials recognize the escalating methamphetamine use as a pivotal factor in the rising rates of HIV. They advocate for evidence-based harm reduction strategies, such as the Needle Syringe Program, to mitigate the potential health crisis stemming from unsafe injection practices. This approach echoes the calls from community advocates who emphasize that access to clean needles is crucial to combat the trend of needle sharing and to reduce new infections.
The growing concern surrounding drug-related health issues in Fiji was further reiterated in related reports acknowledging that around 552 new HIV cases were documented in just the first half of 2024, with 85 cases attributed to injection drug use. The need for comprehensive strategies, including community engagement and education, is paramount in addressing both rising drug use and associated health risks.
While the current situation is dire, there is hope as health officials and community leaders work collaboratively towards implementing strategies that could significantly lessen the incidence of HIV and support affected individuals. With a focus on harm reduction and comprehensive public health initiatives, Fiji can strive toward a healthier future for its communities.